Emerging in the landscape of obesity treatment, retatrutide represents a different strategy. Different from many existing medications, retatrutide works as a double agonist, simultaneously targeting both GLP peptide-1 https://joyceznpd190469.isblog.net/the-innovative-retatrutide-a-glp-and-gip-binding-site-agonist-55706960